台灣臨床試驗主持人資料庫|TPIDB

2016-06-01 - 2019-12-31

Phase I

Completed

Condition/Disease
Test Drug

Participate Sites
4Sites

Terminated4Sites

2017-09-01 - 2021-12-31

Phase I

An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007

Condition/Disease

Breast Cancer
Test Drug

Oraxol

Participate Sites
7Sites

Terminated6Sites

趙祖怡

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Hematology & Oncology

趙大中

Taipei Veterans General Hospital

Division of Radiation Therapy

2018-09-01 - 2019-02-28

Phase I

Condition/Disease
Test Drug

Participate Sites
3Sites

Terminated3Sites

趙祖怡

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Hematology & Oncology

2018-10-16 - 2019-12-31

Others

Condition/Disease
Test Drug

Participate Sites
3Sites

Terminated3Sites

趙祖怡

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Hematology & Oncology

2017-04-01 - 2020-06-01

Phase III

Open-label extension study to evaluate the long-term safety and tolerability of dupilumab inpatients with asthma who participated in a previous dupilumab asthma clinical study

Condition/Disease

asthma
Test Drug

Dupilumab

Participate Sites
4Sites

Terminated3Sites

李岡遠

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Thoracic Medicine

鍾啟禮

Taipei Medical University Hospital

Division of Thoracic Medicine

2015-08-01 - 2017-12-31

Phase III

A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of dupilumab in patients with persistent asthma

Condition/Disease

persistent asthma
Test Drug

dupilumab

Participate Sites
12Sites

Terminated10Sites

李岡遠

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Cardiovascular Diseases

鍾啟禮

Taipei WanFang Hospital (Managed by Taipei Medical Univeristy)

Division of Cardiovascular Diseases

2019-06-01 - 2022-12-31

Phase II

A PHASE 2, OPEN-LABEL, RANDOMIZED, PARALLEL GROUP, CONTROLLED STUDY OF PEMETREXED MAINTENANCE WITH OR WITHOUT ADXS11-001 IMMUNOTHERAPY IN SUBJECTS WITH HUMAN PAPILLOMAVIRUS-POSITIVE, NON-SQUAMOUS, NONSMALL CELL LUNG CARCINOMA FOLLOWING FIRST-LINE INDUCTION CHEMOTHERAPY

Condition/Disease

LUNG CARCINOMA
Test Drug

ADXS11-001

Participate Sites
9Sites

Terminated9Sites

李岡遠

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Thoracic Medicine

2017-07-01 - 2019-09-09

Phase III

A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Subjects Assessed to be at Imminent Risk for Suicide

Condition/Disease

Major Depressive Disorder
Test Drug

ESKETAMINE

Participate Sites
4Sites

Terminated4Sites

李信謙

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Psychiatry

2016-10-21 - 2018-11-19

Phase II

A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered ALS-008176 Regimens in Adult Subjects Hospitalized with Respiratory Syncytial Virus

Condition/Disease

Respiratory Syncytial Virus (RSV)
Test Drug

ALS-008176 (JNJ-64041575)

Participate Sites
6Sites

Terminated6Sites

李岡遠

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Thoracic Medicine

2016-12-01 - 2018-06-30

Phase III

An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

Condition/Disease

Treatment-resistant Depression
Test Drug

ESKETAMINE

Participate Sites
8Sites

Terminated8Sites

李信謙

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Psychiatry

劉嘉逸

Linkou Chang Gung Medical Foundation

Division of Psychiatry

Search Result

List